Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

08/07/2021 07:00

Jul 8 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2021        May 31, 2020     Feb 28, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               27.76               24.88           122.90    
                   (+11.6 pct)         (-14.9 pct)      (+7.3 pct)  
  Operating            2.12                1.08            10.70    
                   (+96.6 pct)         (-61.2 pct)      (+0.3 pct)  
  Recurring            2.86              418 mln           12.70    
                  (+582.9 pct)         (-85.4 pct)      (+7.4 pct)  
  Net                  2.36              113 mln            9.90    
                  (+1979.9 pct)        (-94.1 pct)      (+7.0 pct)  
  EPS               28.91 yen           1.39 yen        121.12 yen  
  EPS Diluted       28.89 yen           1.39 yen                    
  Ann Div                               83.50 yen        84.00 yen  
  -Q2 div                               41.75 yen        42.00 yen  
  -Q4 div                               41.75 yen        42.00 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T